Bank Julius Baer & Co
TXG icon

Bank Julius Baer & Co’s 10x Genomics TXG Stock Holding History

Bank Julius Baer & Co’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10
Closed -$113 – 711
2025
Q3 		$113 Buy
+10
New +$130 ﹤0.01% 664
2022
Q1 		– Sell
-100
Closed -$15K – 793
2021
Q4 		$15K Hold
100
– – ﹤0.01% 767
2021
Q3 		$15K Sell
100
-6,289
-98% -$1.08M ﹤0.01% 763
2021
Q2 		$1.25M Sell
6,389
-36,382
-85% -$6.58M 0.01% 322
2021
Q1 		$7.74M Sell
42,771
-2,928
-6% -$506K 0.06% 166
2020
Q4 		$6.47M Buy
45,699
+19,448
+74% +$2.82M 0.05% 172
2020
Q3 		$3.27M Buy
+26,251
New +$2.76M 0.03% 179

Other funds holding TXG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank Julius Baer & Co's TXG Position: Q4 2025 in Review

Bank Julius Baer & Co sold out of 10x Genomics (TXG) in Q4 2025, closing a stake of 10 shares — an estimated $113 sold.

Bank Julius Baer & Co first reported a position in TXG in Q3 2020 and held it in 7 quarters. The position peaked at $7.74M in Q1 2021. 322 funds tracked by Wall St. Rank hold TXG as of Q4 2025.

  • Bank Julius Baer & Co reported no remaining 10x Genomics position as of Q4 2025 after selling out during the quarter.
  • Bank Julius Baer & Co sold 10 10x Genomics shares in Q4 2025, an estimated $113.
  • Bank Julius Baer & Co first reported a position in 10x Genomics in Q3 2020 and held it in 7 quarters.
  • Bank Julius Baer & Co's 10x Genomics position peaked at $7.74M in Q1 2021.
  • 322 funds tracked by Wall St. Rank held 10x Genomics as of Q4 2025.

Based on Bank Julius Baer & Co's 13F filing for Q4 2025, filed 5 Feb 2026.